本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ascendis Pharma A/S

174.96
-1.5300-0.87%
盤後174.960.00000.00%17:23 EDT
成交量:38.73萬
成交額:6,787.28萬
市值:105.95億
市盈率:-27.80
高:177.18
開:176.42
低:173.78
收:176.49
資料載入中...
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/12

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities